Evolution of the Average Target: Amplifon

Evolution of the Target Price: Amplifon

Changes in Analyst Recommendations: Amplifon

f618d.pFKHT41EiRxASqmIJhwoaN9lVtMXFz3XcYN3J57abZs.3irxdtkN61sKDcT5ZENbL603ZOZ9eVSTHq49ctqDHvLsNvAcvT64bC0F_A~142d6f3f0685f6e58c2d325e19aa7300
Sep. 03 Morgan Stanley Begins Amplifon with Overweight Rating MT
Aug. 21 Intesa Sanpaolo Upgrades Amplifon to Buy, Reduces PT MT
Jul. 31 Amplifon: Profitability beat and improving fundamentals point to a guidance upgrade Alphavalue
Jul. 31 Banca Akros Upgrades Amplifon to Accumulate, Lifts PT MT
Jul. 27 JPMorgan Upgrades Amplifon to Overweight Rating MT
Jul. 16 MedTech facing a three-front squeeze Alphavalue
Jul. 03 Amplifon rallies on the Milan exchange after Equita's buy call AN
Jun. 19 AlphaValue/Baader Europe Upgrades Amplifon to Buy, Lifts PT MT
May. 25 Kepler Cheuvreux Upgrades Amplifon to Buy, Boosts PT MT
May. 13 Amplifon Price Target Rises as Bernstein Ups Estimates Post Q1 Results; Market-perform Rating Kept MT
May. 06 Morningstar Downgrades Amplifon to Hold, Lifts PT MT
May. 05 Amplifon: Promising start to 2026 Alphavalue
Apr. 02 BNP Paribas Downgrades Amplifon to Neutral, Cuts PT MT
Mar. 26 Amplifon: Hardship persists Alphavalue
Mar. 18 Jefferies Downgrades Amplifon to Hold Rating, Cuts PT MT
Mar. 18 Barclays Downgrades Amplifon to Equalweight, Cuts PT MT
Mar. 17 Equita SIM Downgrades Amplifon to Hold Rating, Cuts PT MT
Mar. 16 Amplifon shares tumble following external growth operation Zonebourse
Mar. 16 Amplifon: Amplifon is hunting big game Alphavalue
Mar. 05 Amplifon: Q4 miss rattles market's faith in delivering on next year's targets Alphavalue
Feb. 11 Morningstar Kicks Off Amplifon Coverage with Hold Rating MT
Dec. 08 AlphaValue/Baader Europe Cuts Amplifon Price Target, Estimates Amid Ongoing Macro Headwinds MT
Dec. 05 Amplifon target cut amid market slowdown Alphavalue
Nov. 19 RBC Capital Starts Amplifon Coverage with Sector Perform Rating MT
Nov. 19 RBC Initiates Amplifon at Sector Perform, Notes 'Balanced' Risk-Reward Amid Market Weakness MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+18.73%
+18.27%
+20.31%
+6.44%
+28.59%
+9.07%
+28.35%
+10.02%
+10.88%
Average +16.74%
Weighted average by Cap. +17.81%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
11.42EUR
Average target price
13.62EUR
Spread / Average Target
+19.26%
High Price Target
16.70EUR
Spread / Highest target
+46.17%
Low Price Target
11.10EUR
Spread / Lowest Target
-2.84%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
AA